Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
zolmitriptan 5-hydroxytryptamine receptor 1a small molecule NA drugbank , DGIDB Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.51 approved,investigational agonist
zolmitriptan 5-ht 1b receptor NA Successful target TTD , DGIDB Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
2.61 approved unknown
zolmitriptan 5-ht 1b receptor NA Successful target TTD , DGIDB Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
2.61 approved agonist
zolmitriptan 5-hydroxytryptamine receptor 1b small molecule NA drugbank , DGIDB Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
2.61 approved,investigational agonist
zolmitriptan 5-ht 1d receptor NA Successful target TTD , DGIDB Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
2.83 approved unknown
zolmitriptan 5-hydroxytryptamine receptor 1d small molecule NA drugbank , DGIDB Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
2.83 approved,investigational agonist
zolmitriptan 5-ht 1d receptor NA Successful target TTD , DGIDB Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
2.83 approved agonist
zolmitriptan 5-hydroxytryptamine receptor 1e small molecule NA drugbank , DGIDB Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.96 approved,investigational agonist
zolmitriptan 5-hydroxytryptamine receptor 1f small molecule NA drugbank , DGIDB Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
4.02 approved,investigational agonist
zolmitriptan 5-hydroxytryptamine receptor 2a small molecule NA drugbank Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved,investigational agonist
zolmitriptan 5-hydroxytryptamine receptor 2b small molecule NA drugbank Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved,investigational agonist
zolmitriptan 5-hydroxytryptamine receptor 7 small molecule NA drugbank Aura[MeSHID:D004827]
Migraine Disorders[MeSHID:D008881]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved,investigational agonist
click here to return to the previous page